Dermatology Search
Dermatology Dermatology
atopic%20dermatitis
ATOPIC DERMATITIS
Atopic dermatitis or atopic eczema is a chronic, relapsing, familial, symmetric and pruritic inflammatory skin disease that commonly presents during early infancy and childhood, but can persist or start in adulthood.
It is commonly associated with elevated serum immunoglobulin E levels and a personal or family history of allergies, allergic rhinitis and asthma.
It is one of the most common skin diseases afflicting both children and adults.

Atopic Dermatitis Drug Information

Drug Information

Indication: Moderate to severe atopic dermatitis in adult patients inadequately controlled w/ topical prescription therapi...

Indication: Prophylaxis of transplant rejection in adult kidney or liver allograft receipients. Kidney or liver allograft ...

Indication: Short-term treatment & intermittent long-term therapy of mild to moderate of atopic dermatitis in non-immu...

Indication: Strengthen skin's protective function; increases moisture & lipid content. Reduces feeling of tautness &am...

Palmer's Cocoa Butter Formula Scar Serum
allium cepa + cocoa butter + shark liver oil + sil...

Indication: Hastens healing & reduces appearance of scars resulting from surgery, burns, cuts, scrapes, acne, stretch ...

Indication: Primary immunosuppression in liver & kidney allograft recipients & liver & kidney allograft reject...

Indication: Soap-free cleanser for dry & sensitive skin.

Indication: Moisturising treatment for dry, sensitive skin including dry skin associated w/ eczema, dermatitis & other...

Indication: Eczema including atopic, infantile & discoid eczemas; prurigo nodulis; psoriasis (excluding widespread pla...

Indication: Maintain & improve normal skin condition.

1  /  15
1  /  15
Editor's Recommendations
Most Read Articles
Product Highlight - ADACEL
2 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Carfilzomib-based triplet regimen a potential upfront treatment for high-risk MM
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Alzheimer’s disease prevention: Can antidepressants lend a hand?
Jairia Dela Cruz, Yesterday
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Empagliflozin not just another SGLT2i: Cardio-renal benefits extend to HF with or without diabetes
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.